NOVOSIBIRS, May 22./TASS/. The Russian State Research Center of Virology and Biotechnology Vector plans to submit an application to the World Health Organization (WHO) for the approval of its ...

"The State Research Center of Virology and Biotechnology Vector and its industrial partners have manufactured more than 3.4 million dozes of the vaccine, and 3.1 million doses have been released ...

This project builds on recent work reporting tick transmission of relapsing fever spirochetes and genome sequencing of both the pathogen and tick vector. We have utilized both next generation and ...

Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral ...

Viral Vector Development MarketThe Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, ...

Phase 1 study and Investigator Initiated Trial evaluating KL003 for patients with beta thalassemia demonstrated an encouraging efficacy signal ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector ...

CubeSatGPT™ enables anyone to communicate with satellites and their payloads launched by Vector Space Biosciences. 50+ Waterbears (Tardigrades) will b ...

Matica Biotechnology, Inc. (Matica Bio), a CDMO specializing in viral vector development and manufacturing, today announced the appointment of Min Par ...